⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 5, 2024Journal of Medicinal Chemistry

Discovery of Potent and Selective PI3Kδ Inhibitors for the Treatment of Acute Myeloid Leukemia

Yongmei Tang Yanan Zheng Xueping Hu Huajun Zhao Sunliang Cui

View Full Paper

Ask AI

Bookmark

Share

Abstract

PI3Kδ is an essential target correlated to the occurrence and development of acute myeloid leukemia (AML). Herein, we investigated the pyrazolo[3,4-

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tang et al. (2024) studied this question.

synapsesocial.com/papers/68e70328b6db64358767d5d8 https://doi.org/10.1021/acs.jmedchem.4c00094

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Discovery of Pyrazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors2024 · 6 citations
2Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic StabilityOriginal Research · 2016 · 47 citations
3Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ–PI3Kδ Dual InhibitorsOriginal Research · 2019 · 36 citations
4Discovery of Novel Disubstituted <scp>l</scp> -Prolinamide Derivatives as Selective PI3Kα Inhibitors for Anticancer TherapyOriginal Research · 2026 · 1 citations
5Discovery of Novel Azaindoles as Potent and Selective PI3Kδ Inhibitors for Treatment of Multiple Sclerosis2024 · 3 citations